Effect of Short-Term Stimulation with Interleukin-1β and Differentiation
Medium on Human Mesenchymal Stromal Cell Paracrine Activity in Coculture with
Osteoblasts by Voss, Jan O. et al.
Research Article
Effect of Short-Term Stimulation with Interleukin-1𝛽 and
Differentiation Medium on Human Mesenchymal Stromal Cell
Paracrine Activity in Coculture with Osteoblasts
Jan O. Voss,1,2 Claudia Loebel,1 Jennifer J. Bara,1 Marc Anton Fussinger,1,3
Fabian Duttenhoefer,3 Mauro Alini,1 and Martin J. Stoddart1
1AO Research Institute Davos, 7270 Davos Platz, Switzerland
2Department of Oral and Maxillofacial Surgery/Clinical Navigation, Charite´-Universita¨tsmedizin Berlin,
Campus Virchow-Clinic, 13353 Berlin, Germany
3Department of Oral and Maxillofacial Surgery, Medical Center-University of Freiburg, 79106 Freiburg, Germany
Correspondence should be addressed to Martin J. Stoddart; martin.stoddart@aofoundation.org
Received 4 August 2015; Revised 10 November 2015; Accepted 26 November 2015
Academic Editor: Limei Qiu
Copyright © 2015 Jan O. Voss et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Introduction.Human mesenchymal stromal cells (hMSCs) exhibit the potential to accelerate bone healing by enhanced osteogenic
differentiation. Interleukin-1𝛽 is highly expressed during fracture healing and has been demonstrated to exert a significant impact
on the differentiation behaviour of hMSCs. Here, we investigate the effect of 2-hour IL-1𝛽 stimulation on the differentiation and
paracrine activity of hMSCs in coculture with osteosarcoma cells in vitro. Methods. hMSCs from 3 donors were incubated for 2
hours with 10 ng/mL IL-1𝛽 and subsequently cocultured with MG63-GFP cells either in control or in differentiation medium in a
transwell system for 28 days. Genetic and functional effects were investigated.Results. hMSCs cultured in controlmedium exhibited
a regulatory effect on cocultured MG63-GFP cells, resulting in upregulation of osteogenic gene expression in combination with
increased ALP activity. However, while stimulated hMSCs cultured under differentiation conditions exhibit signs of osteogenic
differentiation, osteogenic differentiation also caused an impaired regulatory effect on the coculturedMG63-GFP cells. Conclusion.
Short stimulation of hMSCs has the potential to modify their long-term behaviour. In addition, undifferentiated hMSCs are able
to regulate osteoblast differentiation; however, this regulatory function is lost upon osteogenic differentiation in vitro. This offers a
novel approach for clinical cell therapy protocols.
1. Introduction
Effective treatment of bone defects attributed to atrophy,
trauma, malformation, and radical surgical resection repre-
sents a major clinical challenge. Autologous bone graft trans-
plantation is on the one hand beneficial due to lack of induced
immune response. On the other hand, it creates the need for
secondary surgical procedures, which can cause severe side
effects and donor site morbidity [1, 2]. Different cell types are
currently being investigated for their potential use in bone
repair [3]. In this context, human mesenchymal stromal cells
(hMSCs) are rapidly gaining interest for regenerative medi-
cine approaches. As nonhematopoietic stromal cells, hMSCs
are capable of self-renewal and exhibit the ability to differenti-
ate along multiple mesenchymal lineages such as osteogenic,
chondrogenic, and adipogenic lineages [4]. Besides their
direct differentiation potential, transplanted cells may exert
a great influence on the surrounding cell microenvironment
indirectly by the paracrine secretion of a broad spectrum of
cytokines and growth factors [5].
Bone healing in response to fractures is well orchestrated
and involves a broad spectrum of cytokines during the
different healing phases [6]. Such growth and differentiation
factors exert significant impact on resident cells thereby influ-
encing subsequent repair. The importance of this cytokine
milieu was demonstrated directly in different in vivo
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approaches [7–9] and indirectly by the delayed fracture
healing when hematoma was removed [7]. Proinflammatory
cytokines, such as interleukin-1 (IL-1), interleukin-6 (IL-6),
and tumor necrosis factor-alpha (TNF-𝛼), as well as other
inflammatory cytokinesplay an essential role in the initiation
process of the repair cascade by mediating inflammation,
degradation, and matrix synthesis [10, 11]. The effect of
inflammatory cytokines on cells of mesenchymal origin has
been investigated in various in vitro settings [12–15]. IL-
1𝛽, as one of the most powerful proinflammatory cytokines,
is upregulated in the early phase of fracture healing, pre-
senting bimodal upregulation [10, 16–18]. We and others
have described the modulatory effect of long-term IL-1𝛽
stimulation on the osteogenic differentiation behaviour of
hMSCs, however with conflicting results [19–22]. While the
exact reasons for this are unclear, differences in study design
(young versus older donors, 7-day versus 28-day stimulation)
make direct comparison difficult.
Recently, it has been described that short stimulation
of human adipose-derived mesenchymal stem cells can
influence their differentiation behaviour [23]. In addition, 2-
hour short-term stimulation of bone marrow derived hMSCs
with IL-1𝛽 had a strong impact on protein synthesis and
influenced the secretion of proteins involved in chemotaxis,
inflammation, angiogenesis, and bone formation [24].
The intraoperative usage of autologous hMSCs may be
beneficial for the patient as it avoids in vitro cell manipu-
lation, which is associated with changes in cell behaviour
[25], reduces the risk of contamination, is immunologically
compatible, and minimizes surgical intervention to one
procedure [26].
Considering the potential future use of transient intraop-
erative stimulation for therapeutic purposes, we investigated
the effect of 2-hour IL-1𝛽 stimulation on hMSCs as a proof
of principle. In order to study the effect of IL-1𝛽 on hMSCs,
we used high density micromass culture, which mimics more
closely the cellmicroenvironment in vivo [27]. Additionally, it
has been shown thatmicromasses promote the differentiation
of osteoblast-like cells in comparison to monolayer culture
[28, 29].
In addition to the direct effect of IL-1𝛽 stimulation on
MSC osteogenic differentiation, their regulatory behaviour
towards surrounding cells by indirect coculture was also
investigated. Here, we took advantage of the homogenous cell
population of the MG63 cell line, an osteosarcoma cell line
that exhibits an immature phenotype, arrested at preosteoblas-
tic state, which ensured consistent cell response and con-
ditions when comparing the cell response of different MSC
donors [30]. Indirect coculturewithMG63 cells constitutively
expressing green fluorescent protein (MG63-GFP) was car-
ried out by separating both cells types via a transwell system,
which allows the exchange of soluble factors but avoids direct
cell-cell contact [31].
2. Materials and Methods
2.1. Bone Marrow. Human bone marrow was harvested from
3patients (male : female ratio 1 : 2;mean age 38,33 years; range
25–50 years)with full ethical approval (KEKBern 126/03) and
informed patient consent.
2.2. MSC Isolation and Cell Culture. Mononuclear cells
(MNCs) were isolated by density centrifugation using
Histopaque-1077 (Sigma-Aldrich, St. Louis, USA) as previ-
ously described [4]. In brief, the interphase containing the
mononuclear cell fraction of whole marrow aspirate was col-
lected. To gate out red blood cells, a cell count above 8𝜇mwas
performed using a cell Scepter 2.0 Automated Cell Counter
(Millipore, Darmstadt, Germany). Cells were plated as P0
generation at a cell seeding density of 5 × 104/cm2 in polysty-
rene cell culture flasks (TPP, Trasadingen, Switzerland) with
𝛼-Minimum Essential Medium (𝛼MEM, Gibco/Life Tech-
nologies, Carlsbad, USA) supplemented with 10% MSC
qualified foetal bovine serum (FBS) (Sera Plus, PAN-
Biotech GmbH, Aidenbach, Germany), 1% Pen/Strep (10.000
units/mL Penicillin, 10.000 𝜇g/mL Streptomycin; Life Tech-
nologies, Carlsbad, USA), and 5 ng/mL basic fibroblast
growth factor-2 (bFGF-2, Fitzgerald Industries, Acton, USA).





. The first medium change was carried
out on day 4 in order to let MSCs attach, after which medium
was replaced three times per week.The adherent cell fraction
was plated at 3 × 103 cells/cm2, grown to confluence, and then
cryopreserved in CM (see below) and 10% dimethyl sulfoxide
(Sigma-Aldrich, St. Louis, USA) at 2 × 106 cells/mL (stated
as P0 generation). Prior to experiments, cells were thawed,
seeded at a density of 3 × 103 cells/cm2 in culture flasks, and
expanded until P2.
2.3. Differentiation, IL-1𝛽 Stimulation, andMicromass Forma-
tion. MG63-GFP cell micromass was formed by plating 10 ×
105 MG63 cells retrovirally transduced to express green fluo-
rescent protein (MG63-GFP) [32] in 5 𝜇L of control medium
(CM containing low glucose DMEM supplemented with 10%
FBS and 1% Pen/Strep) on the bottom of a 24-well plate.
MG63-GFP have previously been shown to be phenotypically
indistinguishable from the parent MG63 population [32].
In order to achieve stable micromass formation, cells were
incubated for 3 hours before adding the assigned medium.
HMSCs were incubated as a cell suspension in 3mL CM
for 2 hours with or without 10 ng/mL recombinant human IL-
1𝛽 (PromoKine, Heidelberg, Germany) at room temperature.
Cell suspension was shaken every 15 minutes to allow even
dispersion. Following a centrifugation step, the medium was
discarded and micromasses were formed on 24-well culture
inserts (BD Bioscience, Franklin Lakes, USA, 0.4 𝜇m pore
size). After 3 h incubation, either CM or osteogenic differ-
entiation medium (DM = CM supplemented with 50𝜇g/mL
ascorbic acid, 5mM 𝛽-glycerophosphate, and 10 nM dexam-
ethasone)was added. 24-well inserts were transferred into 24-
well plates in order to achieve a micromass coculture system.
Medium changes were performed three times per week.
2.4. RNA Extraction and Reverse Transcription. RNA extrac-
tion of samples on days 0, 2, and 7 and 0, 14, and 21 was
carried out by using TriReagent and RNeasy Kit (Quiagen,
BioMed Research International 3
Hilden, Germany). After adding TriReagent, polyacryl car-
rier, and 1-bromo-3-chloropropane, the following centrifuga-
tion induced phase fractionation.Theupper phase containing
the RNA was collected, mixed with 70% ethanol, and applied
to RNeasy columns. 100 ng RNA was used for reverse tran-
scription (RT). RT was carried out using TaqMan Reverse
Transcription kit (Applied Biosystems, Foster City, USA).
2.5. Real-Time Polymerase Chain Reaction (rt-PCR). rt-PCR
was performed using QuantStudio 6 and 7 Flex Real-Time
PCRSystem (Life Technologies, Carlsbad,USA).TheCt value
of each samplewas normalized to the expression of the house-
keeping gene RPLP0 (dCt).The expression level of each target
gene was calculated as 2−ddCt normalized to dCt values of the
sample harvested on day 0 [33]. Primer and probes sequences
used are listed in Supplemental Table 1 in Supplementary
Material available online at http://dx.doi.org/10.1155/2015/
714230.
2.6. Deoxyribonucleic Acid (DNA) Assay. On days 14, 21, and
28, micromasses were digested in 0.5mg/mL recombinant
Proteinase K (Roche, Basel, Switzerland) for 16 hours at
56∘C.DNAcontentwasmeasured usingHoechst 33258 (Poly-
sciences, Warrington, USA) assays as described previously
[34]. A DNA standard curve was generated using calf thymus
DNA (Life Technologies, Carlsbad, USA).
2.7. Alkaline Phosphatase (ALP) Protein Activity. Quantita-
tive, colorimetric determination of ALP protein activity was
performed by using Kit number 104 (Sigma-Aldrich, St.
Louis, USA) according to the manufacturer’s instructions.
On days 14 and 21, samples were incubated at 4∘C for 1
hour in 0.1% Triton-X in 10mM Tris-HCl. By measuring
the absorbance of the ALP product (p-nitrophenol) at 𝜆 =
405 nm, the ALP activity was determined. ALP activity was
calculated according to an ALP standard curve. Results
are expressed in nmol of p-nitrophenol formed per minute
related to total DNA amount ((nmol pNP/min) 𝜇g DNA−1)
of parallel cultures.
2.8. Calcium-45 (45Ca) Radioisotope Incorporation. On
day 21, micromass cultures were incubated for 16 hours
with [45Ca]Cl
2
(1.25 𝜇Ci/mL) radioisotope (Perkin Elmer,
Waltham, USA). Following incubation, the medium was
discarded and the samples were washed with PBS. Samples
were dissolved in 70% formic acid at 65∘C for 1 hour and
radioactivity was measured by scintillation counting. Results
are expressed in counts per minute (CPM) related to 𝜇g
DNA (CPM/𝜇g DNA) of parallel cultures.
2.9. Alizarin Red S Staining andQuantification. Following the
fixation of cells with 4% formaldehyde on day 28, staining
was carried out using 40mM Alizarin Red S (ARS) (Sigma-
Aldrich, St. Louis, USA). Quantification was performed by
dissolving bound ARS in 10% acetic acid (Sigma-Aldrich, St.
Louis, USA). Extracted ARS was detected by measuring the
absorbance at 𝜆 = 405 nm. Results are expressed in nmol of
bounded ARS related to 𝜇g DNA (nmol/𝜇g DNA) of parallel
cultures.
































Figure 1: hMSC gene expression profile after 2-hour IL-1𝛽 stimula-
tion. Fold change in relative gene expression of stimulated hMSCs
normalized to unstimulated hMSCs (RPLP at day 0) quantified
by real-time PCR. Bars show the mean ± SEM of 6 different
experiments performed in triplicate per group (𝑛 = 18 per group).
2.10. Statistical Analysis. Each experiment was performed in
triplicate with 3 different donors. Each donor was tested sep-
arately and the data was collated for statistical analysis. Values
are presented as mean ± standard error of the mean (SEM).
Data was tested for normal distribution by D’Agostino-
Pearson omnibus normality test. To test for differences
between the groups, one-way analysis of variance (one-
way ANOVA) was used followed by Bonferroni’s Multiple
Comparison Post Hoc Analysis according to the normality
test result using GraphPad Prism (GraphPad Software, Inc.,
La Jolla, USA). Statistical significance was considered with
𝑝 < 0.05. ( ∗𝑝 ≤ 0.05, ∗∗𝑝 ≤ 0.01, and ∗∗∗𝑝 ≤ 0.001).
3. Results
3.1. IL-1𝛽 Stimulation Induces Transient Osteogenesis-Related
Gene Expression Changes in Human Mesenchymal Stem
Cells. In order to investigate the direct effect of IL-1𝛽 on
hMSCs, the gene expression following 2-hour stimulation
was analysed. Interestingly, shortly after the stimulation with
IL-1𝛽, stimulated hMSCs show downregulation of Runx2,
alkaline phosphatase (ALP), and Type 1 Collagen (Type 1 Col)
compared to unstimulated hMSCs (Figure 1). While these
osteogenic related genes decreased, the gene expression of
Sox9 (a transcription factor related to chondrogenesis and
endochondral bone formation [35]) was strongly upregulated
immediately after stimulation.
Runx2 expression was higher in IL-1𝛽 stimulated hMSCs,
cultured in bothCMandDM, compared to unstimulated cells
on day 2 (Figure 2(a)). At day 7, expression of Runx2 fell and
remained low throughout subsequent culture in all groups
(Figures 2(a) and 2(b)). hMSCs cultured in differentiation
medium showed slightly higher Runx2 gene expression levels
on days 2 and 21 compared to control medium groups.










































































































































































































































































































































































Figure 2: hMSC gene expression. Fold change in relative gene expression of hMSCs normalized to unstimulated hMSCs (RPLP at day 0)
quantified by real-time PCR. Bars show the mean ± SEM of 3 different experiments performed in triplicate per group (𝑛 = 9 per group with
the exception of (e) day 7 in CM + IL-1𝛽, where 𝑛 = 8). D’Agostino-Pearson omnibus normality test was used followed by one-way ANOVA,
∗𝑝 < 0.05. (a) Runx2 on days 2 and 7, (b) Runx2 on days 14 and 21, (c) Sox9 on days 2 and 7, (d) Sox9 on days 14 and 21, (e) ALP on days 2
and 7, (f) ALP on days 14 and 21, (g) Type 1 Col on days 2 and 7, (h) Type 1 Col on days 14 and 21, (i) OC on days 2 and 7, and (j) OC on days
14 and 21.
Sox9 expression was downregulated following osteogenic
induction at days 2 and 7 (Figure 2(c)). IL-1𝛽 stimulation
downregulated Sox9 expression in cells cultured under
basal conditions at day 2 but not in cells cultured in DM
(Figure 2(c)). At days 14 and 21, Sox9 was downregulated in
all groups (Figure 2(d)).
ALP gene expression increased over time in all groups,
with cells cultured in DM and DM + IL-1𝛽 exhibiting an
earlier response compared to CM and CM + IL-1𝛽 groups
(Figure 2(e)). On day 2, IL-1𝛽 stimulated cells cultured in
DM showed significantly higher ALP expression compared
to the CM + IL-1𝛽 group (𝑝 < 0.05, Figure 2(e)). ALP
remained more highly expressed by cells cultured in DM
compared to CM regardless of IL-1𝛽 stimulation at days 14
and 21 (Figure 2(f)).
With regard to Type I Collagen, hMSCs cultured in
control medium (CM and CM + IL-1𝛽) showed decreasing
gene expression over time. In DM and DM + IL-1𝛽 groups,
Type I Collagen gene expression levels peaked at day 14 and
fell by day 21 to levels comparable to earlier time points
(Figures 2(g) and 2(h)).
Osteocalcin (OC) gene expression was downregulated in
all groups throughout the experiment (Figures 2(i) and 2(j)).
hMSCs cultured in DM ± IL-1𝛽 stimulation exhibited a
slightly higher Runx2/Sox9 ratio compared to cells cultured
in CM at days 2 and 7 (Figure 3(a)). Runx2/Sox9 ratios















































Figure 3: Runx2/Sox9 ratio hMSCs. Bars show the mean ± SEM of 3 different experiments performed in triplicate per group based on fold
change in gene expression normalized to day 0 (𝑛 = 3 per group); one-wayANOVAwas used to test for statistical significance. (a) Runx2/Sox9
ratio on days 2 and 7, (b) Runx2/Sox9 ratio on days 14 and 21 (mind the gap in the 𝑦-axis).
decreased at later time points with no significant differences
between groups (Figure 3(b)).
3.2. Paracrine Modulation of MG63-GFP Gene Expression Is
Dependent upon hMSC Differentiation Status. MG63-GFP
cells cocultured with IL-1𝛽 stimulated hMSCs upregulated
Runx2 gene expression in both CM and DMmedia on day 2.
Over time, Runx2 gene expression in all 4 groups decreased
to comparable levels and then rose at day 21 (Figures 4(a) and
4(b)). MG63-GFP Runx2 gene expression showed a similar
pattern to hMSCs, with high values on day 2, downregulation
by day 7, and subsequent upregulation on day 21.
Sox9 expression was the highest in all groups on day 2
with downregulation on days 7–14 followed by upregulation
on day 21 (Figures 4(c) and 4(d)). MG63-GFP cells cocul-
tured in control medium exhibited significantly higher Sox9
expression compared to cells cocultured in differentiation
medium at all time points (𝑝 ≤ 0.05, Figures 4(c) and 4(d)).
In all four MG63-GFP groups, ALP gene expression
increased from day 2 to day 14 and then fell at day 21 (Figures
4(e) and 4(f)). ALP gene expression was significantly higher
in CM and CM + IL-1𝛽 groups at later time points compared
to cells cultured in differentiation medium ± IL-1𝛽 (Figures
4(e) and 4(f)).
Type 1 Collagen gene expression of MG63-GFP on day
2 was significantly higher in the CM + IL-1𝛽 compared to
the CM group (𝑝 ≤ 0.05). Over time, CM groups showed
a decrease in ALP expression (Figures 4(g) and 4(h)). MG63-
GFP cells cocultured in DM displayed significant downreg-
ulation in ALP expression at all time points irrespective of
IL-1𝛽 stimulation (Figures 4(g) and 4(h)).
Osteocalcin gene expression was consistently lower in
DM groups compared to CM groups at all time points and
was downregulated in all 4 groups at day 7 (Figure 4(i)).
OC gene expression in all 4 groups increased again with
maximum values at day 21 (Figure 4(j)). MG63-GFP cells in
the DM + IL-1𝛽 group exhibited significantly lower OC gene
expression on day 7 compared to cells in the CM + IL-1𝛽
group (𝑝 ≤ 0.01).
3.3. Elevated Runx2/Sox9 Ratio in MG63-GFP Cells Cocul-
tured with IL-1𝛽 Stimulated hMSCs. TheRunx2/Sox9 ratio of
MG63-GFP cocultured in CM ± IL-1𝛽 stimulation remained
constant throughout the experiment. MG63-GFP cocultured
in DM ± IL-1𝛽 stimulation presented consistently higher
Runx2/Sox9 ratios compared to CM groups, which was
significant at day 7 (DM+ IL-1𝛽 versus CM+ IL-1𝛽, 𝑝 < 0.05,
Figures 5(a) and 5(b)).
3.4. Effect of Transient IL-1𝛽 Stimulation on Proliferation
of hMSCs and MG63-GFP Cells. IL-1𝛽 stimulation had no
effect on hMSC proliferation in coculture with MG63-GFP
(Figure 6(a)). HMSCs cultured in DM showed significantly
higher total DNA content compared to cells incubated in
CM on the same day independent of IL-1𝛽 stimulation
throughout the entire experiment, which is in line with
published work [36]. Similarly, MG63-GFP cells showed
significantly higher total DNA content in DM on all days
analysed compared to cells cultured in CM. DNA content
values for MG63-GFP cocultured in DM with unstimulated
hMSCs (DM) were higher compared to cells cocultured with
stimulated hMSCs (DM + IL-1𝛽). This effect was detectable
at all 3 time points with a significant difference on day 21
(𝑝 ≤ 0.05) (Figure 6(b)).
3.5. Transient IL-1𝛽 Stimulation Modulates ALP Activity in
hMSCs and in MG63-GFP Cells in a Temporal Manner. ALP
activity related to total DNA content was increased in hMSCs



























































































































































































































































































































































































Figure 4:MG63-GFP gene expression. Fold change in relative gene expression ofMG63-GFP cells normalized to RPLP at day 0 quantified by
real-time PCR. Bars show the mean ± SEM of 3 different experiments performed in triplicate per group (𝑛 = 9 per group with the exception
of (a, c, e, g, i, and k) in DM, where 𝑛 = 8). Mean ± SEM; D’Agostino-Pearson omnibus normality test was used followed by one-way ANOVA;
∗𝑝 ≤ 0.05; ∗∗𝑝 ≤ 0.01; ∗∗∗𝑝 ≤ 0.001. (a) Runx2 on days 2 and 7, (b) Runx2 on days 14 and 21, (c) Sox9 on days 2 and 7, (d) Sox9 on days 14
and 21, (e) ALP on days 2 and 7, (f) ALP on days 14 and 21, (g) Type 1 Col on days 2 and 7, (h) Type 1 Col on days 14 and 21, (i) OC on days 2
and 7, and (j) OC on days 14 and 21.
that were stimulated and cultured in differentiation medium
(DM + IL-1𝛽) compared to unstimulated cells (DM) on days
14 and 21. Whilst, on day 14, stimulated hMSCs in control
medium (CM + IL-1𝛽) had slightly lower values compared
to unstimulated cells (CM), on day 21, this correlation is
reversed (Figure 7(a)).
ALP activity in MG63-GFP was significantly higher in
MG63-GFP cells cultured in CM compared to cells cultured
in DM on day 14 (𝑝 ≤ 0.05, 𝑝 ≤ 0.01). Cells cultured with
stimulated hMSCs showed higher ALP activity in bothmedia
(CM + IL-1𝛽 and DM + IL-1𝛽) compared to coculture with
unstimulated hMSCs. Increased ALP activity in MG63-GFP
cells incubated with stimulated hMSCs cells was inverted
on day 21 (Figure 7(b)). This effect indicates that IL-1𝛽
stimulation of hMSCs leads to an earlier response in ALP
activity in MG63-GFP cells with higher values on day 14
and an earlier/stronger drop on day 21, which is in line with
rt-PCR data where an earlier increase in gene expression is
observed between days 2 and 7 (Figures 4(e) and 4(f)).
3.6. Transient IL-1𝛽 Stimulation Has Little Effect on Cal-
cium Deposition in hMSCs Cocultured with MG63-GFP
Cells. HMSCs cultured in DM ± IL-1𝛽 showed significantly
higher 45Ca incorporation on day 21 compared to controls








































Figure 5: Runx2/Sox9 ratio MG63-GFP. Bars show the mean ± SEM of 3 different experiments performed in triplicate per group based on
fold change in gene expression normalized to day 0 (𝑛 = 3 per group); one-way ANOVAwas used to test for statistical significance, ∗𝑝 ≤ 0.05.






















































Figure 6: DNA quantification. Total DNA content expressed in 𝜇g/mL. Bars show the mean ± SEM of 3 different experiments performed in
triplicate per group. D’Agostino-Pearson omnibus normality test was used, followed by one-way ANOVA; ∗𝑝 ≤ 0.05; ∗∗𝑝 ≤ 0.01; ∗∗∗𝑝 ≤
0.001. (a) Total DNA content in hMSC culture on days 14, 21, and 28 (𝑛 = 9 per group). (b) Total DNA content in MG63-GFP cell culture on
days 14, 21, and 28 (𝑛 = 9 per group).





























































Figure 7: Alkaline phosphatase activity. ALP activity is related to total DNA content and expressed in nmol pNP/min/𝜇g DNA. Bars show
the mean ± SEM of 3 different experiments performed in triplicate per group; one-way ANOVA was used to test for statistical significance;
∗𝑝 ≤ 0.05; ∗∗𝑝 ≤ 0.01. (a) ALP activity in hMSC culture on days 14 and 21 (𝑛 = 3 per group). (b) ALP activity in MG63-GFP cell culture on
days 14 and 21 (𝑛 = 3 per group).
(𝑝 ≤ 0.01). IL-1𝛽 stimulation of hMSCs resulted in slightly
lower incorporation of the radioisotope 45Ca on day 21 in
CM + IL-1𝛽 and DM + IL-1𝛽 groups compared to CM and
DM groups (Figure 8(a)). Cocultured MG63-GFP showed
similar results; however, none of the differences were signifi-
cant. Culturing in DM resulted in overall significantly higher
45Ca incorporation on day 21 (𝑝 ≤ 0.01 and 𝑝 ≤ 0.001).
MG63-GFP cells cocultured with stimulated hMSCs in dif-
ferentiation medium (DM + IL-1𝛽) had lower incorporation
numbers than cells cocultured with unstimulated hMSCs
(DM) (Figure 8(b)).
Stimulated hMSCs in CM, as well as in DM, contained
slightly less bound ARS related to total DNA content than
hMSCs without stimulation (Figure 9(a)). In line with the
calcium data, these effects were not significant.
However, MG63-GFP cocultured with stimulated hMSCs
showed similar levels of bound ARS when cultured either in
control medium or in differentiation medium (Figure 9(b)).
Qualitative Alizarin Red S staining showed similar stain-
ing patterns comparing CM and CM + IL-1𝛽, as well as DM
and DM + IL-1𝛽 in both cell types. Culturing hMSCs in
differentiationmedium resulted in pronounced ARS staining
independent of whether hMSCs were previously stimulated
with IL-1𝛽 or not (Figure 10). Additionally,MG63-GFP (a cell
line not normally associated with calcification) exhibited sig-
nificantly greater ARS staining in DM versus CM (Figure 10).
Interestingly, low magnification images of MG63-GFP
cells that had been cultured in differentiation medium (DM
and DM + IL-1𝛽) showed clear delineation between stained
and nonstained areas (Figure 10(a)). Stained areas correlated
with the size and form of the original micromass and were
located directly under the membrane carrying the hMSCs.
Even though cells were detected outside the staining border,
these areas did not reveal calcium deposition.
4. Discussion
Proinflammatory cytokines released during the inflamma-
tory response in the initial phase after a bone fracture exert
a great influence on the behaviour of surrounding cells
involved in the following healing process [10, 37]. IL-1𝛽,
as one of the most powerful proinflammatory cytokines, is
upregulated in the early phase of bone healing after fracture
and is fundamental in the regeneration cascade [17, 18, 38].
While so far many stimulation procedures are based on
continuous administration [12, 20–22], it was previously
shown that short-term stimulation of hMSCs resulted in a
broad gene expression change that persisted over time [23,
24]. Differentiation of MSCs to an osteogenic phenotype
has been shown to reduce the angiogenic profile of the
cells secretome in both equine and human MSCs [39, 40].
However, the effect of MSC osteogenic differentiation on the
cross talk with osteoblasts and their precursors is less clear.
While continuous administrations protocols are costly and
impractical in a direct clinical setting, short-term stimulation
may be performed intraoperatively.
Here, we investigated the direct and indirect long-term
effects of 2-hour short-term IL-1𝛽 stimulation of human
MSCs cocultured with the osteosarcoma cell lineMG63-GFP
in a transwell system that allowed indirect cell communica-
tion.
4.1. IL-1𝛽 Stimulation of hMSCs Resulted in an Early mRNA
Expression Response of Bone Markers. Following the 2-hour

















































Figure 8: 45Ca incorporation related to total DNA content. 45Ca incorporation is related to total DNA content and expressed in cpm/𝜇g
DNA. Bars show the mean ± SEM of 3 different experiments performed in triplicate per group with the exception of (b) where 2 different
experiments were performed; one-way ANOVA was used to test for statistical significance; ∗∗𝑝 ≤ 0.01; ∗∗∗𝑝 ≤ 0.001. (a) Incorporated 45Ca
















































Figure 9: Alizarin Red S quantification. Bounded ARS is related to total DNA content and expressed in nmol/𝜇g DNA. Bars show themean ±
SEM of 3 different experiments performed in triplicate per group with the exception of (b) where 2 different experiments were performed;
one-way ANOVA was used to test for statistical significance. (a) ARS content in hMSC culture on day 28 (𝑛 = 3 per group). (b) ARS content
in MG63-GFP cell culture on day 28 (DM ± IL-1𝛽, 𝑛 = 2 per group; CM ± IL-1𝛽, 𝑛 = 3 per group). Notice: 𝑦-axis is gapped.
stimulation of hMSCs with interleukin-1𝛽, we were able
to demonstrate prompt downregulation of genes related to
osteogenesis (Runx2, ALP, and Type 1 Col) with concomitant
upregulation of Sox9 gene expression (Figure 1). However, by
day 2, these effects weremostly reversed.These findings are in
line with published results by Czekanska et al. who described
significant downregulation of mRNA expression of the bone
markers Runx2 and Sox9 48 hours after 2-hour stimulation
[24]. In line with results published by Czekanska et al., we
could detect a donor dependent variability in the Sox9 gene
expression changes. In addition to changes at the mRNA
level, Czekanska et al. investigated protein levels of cytokines
in medium conditioned by stimulated hMSCs. Stimulation
of hMSCs with IL-1𝛽 had a strong influence on protein
12 BioMed Research International
























Figure 10: Alizarin Red S staining. Alizarin Red S staining of all groups. Results show representatives of 3 different experiments with similar
findings. Row (a) (scale bar: 1mm) and row (c) (CM and CM ± IL-1𝛽, scale bar: 1mm; DM and DM ± IL-1𝛽, scale bar: 500 𝜇m) show 4x
magnification. Rows (b) and (d) show 10x magnification (scale bar: 200 𝜇m).
synthesis, influencing the secretion of proteins involved in
chemotaxis, inflammation, angiogenesis, and bone formation
[24]. Based on these findings, we investigated the effect of
stimulated hMSCs in an indirect coculture with cells of
the osteoblast cell line MG63-GFP exhibiting an immature
osteoblastic phenotype.
4.2. IL-1𝛽 Stimulation of hMSCs Resulted in Transient Changes
in Gene Expression. Following temporary downregulation of
osteogenic related genes 2 hours after stimulation of hMSCs
with IL-1𝛽, mRNAgene expression increased over time again.
In line with previous published work, this effect was highly
donor dependent but shows an overall similar pattern in gene
expression [24].
Runx2, a key transcription factor involved in osteoblast
differentiation and bone formation [41], is generally upregu-
lated in the early phase upon stimulation of hMSCs.The gene
expression of Sox9, a transcription factor related to chondro-
genesis and endochondral bone formation [35], however is
strongly downregulated. The ratio of Sox9 and Runx2 gene
expression is considered to be a critical predictive factor of
direct osteogenesis [41, 42]. We show here that IL-1𝛽 had a
clear influence on the gene expression of both Runx2 and
Sox9 at early time points. Not only did stimulated hMSCs
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show clear upregulation in the Runx2 gene expression in
controlmedium (CM+ IL-1𝛽) on days 2 and 21 and differenti-
ationmedium (DM+ IL-1𝛽) at day 2, but also at the same time
the stimulation of hMSCs resulted in strong downregulation
of Sox9 gene expression. Similar results were presented by
Murakami et al. in mouse chondrocytes [35] and by Wehling
et al. in humanMSCs [43]. The downregulation in Sox9 gene
expression could also be detected in the unstimulated hMSC
group cultured in differentiationmedium (DM) and is also in
line with previous published work [42].
TheRunx2/Sox9 ratiowas recently described as an impor-
tant indicator for the responsiveness of human bone marrow
derived hMSCs regarding their osteogenic differentiation
potential [42]. By increasing the Runx2 expression and
simultaneously decreasing Sox9 expression, IL-1𝛽 stimulated
hMSCs showed a higher Runx2/Sox9 ratio in differentiation
and culture medium in early time points with the highest
ratio in DM + IL-1𝛽 group on day 2. While Loebel et al.
attributed Runx2/Sox9 ratio on day 7 as a powerful predictor
of osteogenic development, our data presented here confirm
day 2 as being a useful time point as well [42]. Early changes
induced by transient stimulation have been shown to have
longer term effects. 30min incubation of mouse MSCs with
IGF-1 has been shown to increase cell survival after engraft-
ment [44]. Further work would be required to establish the
in vivo effect of transient IL-1𝛽 stimulation. At later time
points, IL-1𝛽 stimulated cells cultured in control medium led
to an even higher Runx2/Sox9 ratio than in cells cultured in
differentiation medium. This would suggest that these cells
were undergoing delayed spontaneous differentiation.
IL-1𝛽 stimulated hMSCs cultured in control medium
demonstrated higher levels of Type 1 Collagen gene expres-
sion compared to unstimulated cells which peaked earlier
in comparison to stimulated cells in differentiation medium.
ALP gene expression is increased throughout the time and
shows overall higher expression in cells cultured in differen-
tiation medium.
Normally, Type 1 Collagen is upregulated during the
proliferation phase, with its fibril formation being responsible
for matrix formation in vivo, while ALP gene expression
is upregulated during the early stages of matrix synthesis,
peaking around day 14 and subsequently leading to matrix
maturation and mineralisation [45].
The consistent downregulation of Osteocalcin in all 4
groups throughout the experiment is not unusual. Jaiswal
et al. suggested that Osteocalcin might not be a reliable
marker for osteogenic differentiation due to the inhibitory
effect of dexamethasone on Osteocalcin mRNA expression
[46].
Attention should be paid to the fact that the beneficial
effect of IL-1𝛽 after a short administration time is mostly
evident in early time points. However, this effect occurs
during the critical initial engraftment period, when the
healing response is initiated.
4.3. ALP Activity Is Enhanced after Stimulation without
Changes in Calcium Deposition. Regarding the cell viability,
neither IL-1𝛽 alone nor IL-1𝛽 in combination with dexam-
ethasone reduced total DNA content in the hMSC samples,
similar to previously published results [19]. Furthermore,
continuous administration of IL-1𝛽 resulted in an increase of
totalDNAcontent [20]. In linewith these results, Gowen et al.
could show an increase in proliferation in human bone cells
when cultured in IL-1 containing medium [47].
ALP is considered to be amarker for osteoblastic differen-
tiation that reaches itsmaximumduring early stages ofmatrix
maturation [48]. Stimulation of hMSCs with IL-1𝛽 led to an
increase in ALP activity. This effect was more obvious when
cells were cultured in differentiation medium compared to
the control group, which is in line with published work show-
ing that cell cultures grown in the presence of dexamethasone
presented induction of ALP activity [36, 49]. Ferreira et al.
however did not detect any changes inALP activity compared
to cells cultured in medium containing dexamethasone. This
might be explained by the long-term culturing/stimulation
approaches with IL-1𝛽 [19].
Quantification of incorporated 45Ca revealed similar
values in stimulated cell groups in both types of media.
Comparable results could be found when looking at the ARS
quantification.
In addition, it has to be taken into consideration that the
Calcium-45 measurement only represents a sequence of the
passing calcification/mineralisation process. This process is
highly donor dependent and provides the information about
the Calcium-45 uptake at that given time point.This can lead
to misinterpretation, as an antedated calcification process
would have lower uptake as an ongoing process.
Furthermore, qualitative comparison of ARS staining
showed no clear difference between stimulated and unstim-
ulated groups. This effect might be described by previous
work claiming that it needed at least a minimum of 14 days
of continuous IL-1𝛽 application to be effective in inducing
mineralisation response [19]. These findings could be an
explanation for the comparable values in the 45Ca incorpo-
ration and ARS quantification measurements. Similar results
were described by Loebel et al. and Sonomoto et al. who
administered the IL-1𝛽 for 10 and 28 days, respectively, in
order to detect a distinct difference [20, 22].
4.4. Stimulated hMSCs Evoke Upregulation of Genes inMG63-
GFP Cells. The stimulation of hMSCs and subsequent cul-
turing in the two different media revealed diverse effects.
While the stimulation of hMSCs in osteogenic medium
depicted a strong stimulus towards an osteogenic differen-
tiation behaviour in hMSCs, these cells subsequently lost
their stimulatory capacities guiding MG63-GFP cells in their
further differentiation at the mRNA level. Stimulated hMSCs
cultured in control medium however abided in a more
undifferentiated stage but exhibited a distinct capability to
stimulate the cocultured MG63-GFP cells in their differ-
entiation behaviour. MG63-GFP cells under the influence
of stimulated hMSCs showed a stronger response in Type
1 Collagen gene expression on day 2 when cultured in
control medium (CM + IL-1𝛽) compared to the differen-
tiation group (DM and DM + IL-1𝛽). Over time, Type 1
Collagen gene expression was decreased and simultaneously
the gene expression of ALP in MG63-GFP cells cocultured
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with stimulated hMSCs in control medium (CM+ IL-1𝛽) was
increasingly upregulated. Starting around day 14, Osteocalcin
gene expression in MG63-GFP cells cultured in control
medium with un- or stimulated cells (CM and CM + IL-
1𝛽) started rapidly to increase. These effects were either
not seen or just slightly distinct when cells were cocultured
with hMSCs in differentiation medium (DM and DM +
IL-1𝛽). Concerning the observed gene expression pattern,
differentiated hMSCs (upregulated ALP and Type 1 Col)
exhibit a distinct impaired stimulatory effect towards MG63-
GFP cells. Stimulated undifferentiated hMSCs (CM + IL-1𝛽)
instead take up a more regulatory/stimulatory role that
evokes upregulation of gene expression in MG63-GFP cells.
It is noteworthy that the Type 1 Collagen, ALP, and
OC gene expression in MG63-GFP cells cocultured with
unstimulated hMSCs in differentiation medium (DM) were
expressed to a higher level compared to previously published
results [50].
Interestingly, MG63-GFP cells cultured in differentiation
medium with stimulated hMSCs showed a significantly
lower DNA content compared to the control group (DM)
(Figure 6(b)). This effect was only visible when cells were
cultured in differentiation medium.
Dedhar found regulation in the expression of the cell
adhesion receptors (mainly integrins), stimulation of ALP
activity, while cell proliferation was inhibited by direct stim-
ulation of MG63 cells with recombinant human IL-1𝛽 [51].
Dedhar concluded that the stimulus would inhibit mainly
cells that exhibit a high proliferation rate thereby shifting to a
more differentiated osteoblastic cell type that expresses a
higher alkaline activity [51]. Keeping in mind that only
hMSCs were exposed to transient IL-1𝛽 stimulation, the
changes in MG63-GFP phenotype indicate an indirect
response to the hMSC conditioned environment. Moreover,
Czekanska et al. detected upregulation of IL-1𝛽 gene expres-
sion 72 hours after stimulating hMSCs with IL-1𝛽 [24].
Czekanska et al. described in previous work a low ALP
activity with a maximum of enzyme activity on day 28 in
MG63 cultured as monolayer cell formation under the influ-
ence of osteogenic medium [50]. Interestingly, we detected
the ALP activity increasing around day 14 with a decrease
towards day 21, which is in line with the ALP gene expression
pattern, with a maximum around day 14 in MG63-GFP cells
cultured in control medium. Coculturing of MG63-GFP cells
with stimulated hMSCs in micromass formation resulted in
an earlier ALP activity peak in MG63-GFP cells compared to
the other groups.
Striking are the opposite responses in ALP gene expres-
sion seen when comparing hMSCs and MG63-GFP cells.
HMSCs cultured in differentiation medium show the highest
ALP gene expression (Figures 2(e) and 2(f)), while MG63-
GFP cells show strong upregulation of ALP gene expres-
sion when cocultured in control medium, whereas the cells
cultured in differentiation medium feature a slight increase
(Figures 4(e) and 4(f)). Besides the mentioned observation,
±IL-1𝛽 treatment reveals an additional remarkable effect:
hMSCs treated with IL-1𝛽 (CM + IL-1𝛽) have a contrary ALP
expression behaviour in contrast to MG63-GFP cells in the
coculture (CM + IL-1𝛽). The same effect is detectable when
comparing unstimulated hMSCs cultured in control medium
(CM) and MG63-GFP (CM). Upregulation in ALP gene
expression in hMSCs (±IL-1𝛽) resulted in downregulation in
MG63-GFP gene expression and vice versa.
Despite the dramatic changes seen in gene expression
and ALP protein activity in MG63-GFP cells cocultured with
hMSCs in control medium, no calcification was observed.
This would suggest that a critical element is missing inMG63
at the later stages of differentiation, which is not sufficiently
provided by the paracrine activity of na¨ıve MSCs.
However, MG63-GFP cocultured with hMSCs in dif-
ferentiation medium displayed robust calcification. Earlier
studies have claimed a low protein synthesis in combination
with a low ALP activity to be responsible for insufficient
matrix maturation thereby leading to precluding calcifica-
tion of MG63 cells [50]. Previous groups did detect a cell
layer formed by MG63 cells after monolayer cell culture
but without any signs of calcium deposition even after 28
days of cell culture [50, 52]. Here, we showed clear matrix
mineralization in both groups cultured in differentiation
medium (DM and DM + IL-1𝛽) on day 28. This is the most
novel aspect of the work presented; the mineralization of
MG63 in coculture offers a unique system to investigate the
critical steps of late stage osteogenic differentiation. One
reason might be the different cell formation as we cultured
the cells in amicromass construct. However, previousMG63-
GFP micromass cultures did not calcify in the absence of
hMSCs (data not shown). Considering the coculture with un-
or stimulated hMSCs, it is also possible that by indirect cell
communication MG63-GFP cells started to deposit calcium
as the ARS stained only areas of the MG63-GFP cells
formation that were directly located underneath the hMSCs
cell formation. Considering the fact that the stained areas
are located directly under the membrane carrying hMSCs,
hMSCs seem to promote MG63-GFP calcification.
One possible explanation could be that secreted
molecules by hMSCs fall due to gravity onto the MG63-
GFP cells below the transwell system rather than being
homogenously distributed in themedium.Thereby, only cells
that are located directly underneath the membrane would
be influenced by the secretome of hMSC cells. As soluble
mediators would not exhibit such activity, a more likely
explanation would be extracellular vesicles (EVs), containing
proteins, mRNA, and microRNA, which could play a role as
key elements of the stem cell paracrine activity [53, 54]. EVs
include exosomes, which are 30–100 nm diameter vesicles
of endocytic origin, and microvesicles (MVs), which are
100 nm–1𝜇m diameter vesicles directly shed from the cell
membrane [53, 54]. Vesicles produced by the osteogenically
differentiated hMSCs would then be able to fall through the
transwell membrane pores and thus signal to the cells directly
below. The contents of these vesicles are the likely source of
the required signals that allow theMG63-GFP cells to calcify.
5. Conclusion
Bone healing involves well-orchestrated interplay between
cells and the surrounding cytokine milieu. Besides cell-
cell contact, indirect cell interactions (by secreting a broad
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spectrum of growth and differentiation factors) play a major
role in the ongoing healing process. Here, we show that short-
term stimulation of hMSCs with IL-1𝛽 was sufficient enough
to cause a change in gene expression. Besides having an
impact on the differentiation process of immature hMSCs,
less differentiated IL-1𝛽 stimulated hMSCs exhibit a more
regulatory behaviour towards the surrounding cells, leading
to upregulation of genes in MG63-GFP osteoblasts. These
results indicate that short stimulation of hMSCs has the
potential to modify short-term osteogenesis-related gene
expression, as well as influencing the surrounding cell milieu,
and offers a novel tool for clinical cell therapy approaches in
translational medicine.
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